TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'This Pipeline Is Impressive', 'Buy BHVN'
Tweet Send to a Friend
TD Cowen analyst Tyler Van Buren reiterated a Buy rating and $75.00 price target on Biohaven Pharmaceutical Holding (NYSE: BHVN)The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
